SERPINB5
SERPINB5 Gene: Unraveling the Enigma of Coagulation and Fibrinolysis
Description
The SERPINB5 gene, located on chromosome 18q21.3, encodes serpin family B member 5 (SERPINB5), a crucial protein involved in blood coagulation and fibrinolysis. SERPINB5 belongs to the serpin superfamily, a group of protease inhibitors with distinctive structural and functional features.
SERPINB5 primarily acts as an inhibitor of tissue-type plasminogen activator (tPA), a serine protease that triggers fibrinolysis, the process of clot dissolution. By suppressing tPA activity, SERPINB5 plays a pivotal role in maintaining the integrity of blood clots and preventing premature dissolution.
Associated Diseases
Mutations in the SERPINB5 gene have been associated with a range of bleeding disorders and thrombotic conditions, including:
- Congenital SERPINB5 deficiency: A rare, autosomal recessive disorder characterized by a severe bleeding tendency due to impaired fibrinolysis.
- Inherited thrombophilia: An increased risk of developing blood clots, often associated with mutations in SERPINB5 that lead to reduced protein activity.
- Venous thromboembolism (VTE): A serious condition where blood clots form in the veins, potentially leading to pulmonary embolism or deep vein thrombosis.
- Intrauterine growth restriction (IUGR): In women with SERPINB5 mutations, IUGR may occur due to impaired placental blood flow.
Did you Know ?
Approximately 1 in 500 individuals carries a mutation in the SERPINB5 gene. The prevalence of these mutations varies across different populations, with higher frequencies observed in certain ethnic groups.
